Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Avacta Announces AffyXell Expands Its Strategic Partnership With GenScript ProBio
Avacta Group plc (AIM: AVCT), a clinical stage oncology drug company developing innovative cancer therapies […]
Tribute to His Royal Highness The Prince Philip Duke of Edinburgh at Heart of Steel
We’ve recognised the lifelong contributions of our Royal Patron, The Prince Philip HRH Duke of […]
Sarclisa® (Isatuximab) Combination Provides Unprecedented Median Progression Free Survival in Patients With Relapsed Multiple Myeloma Receiving a Proteasome Inhibitor Therapy
Latest results from the Phase 3 IKEMA clinical trial evaluating Sarclisa® (isatuximab) in combination with carfilzomib […]
Hundreds of Patients to Get Life-extending Lung Cancer Drug on the NHS
Hundreds of people with a form of the most common form of lung cancer could […]
ADA Names Charles D. Henderson as New Chief Executive Officer
The American Diabetes Association® (ADA), the nation’s leading voluntary health organization fighting to bend the curve […]
Movano Successfully Completes Functional Testing of Smallest Ever Custom mmWave Sensor Designed for Non-Invasive Glucose and Cuffless Blood Pressure Monitoring
Movano Inc. (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices, announces […]
Roche Enters Partnership With the Global Fund to Support Low- and Middle-income Countries in Strengthening Critical Diagnostics Infrastructure
Roche (SIX: RO, ROG; OTCQX: RHHBY), through its Global Access Program, and The Global Fund […]
Targovax Announces Clinical Collaboration With Agenus for Upcoming ONCOS-102 Phase 2 Melanoma Trial
Targovax ASA (OSE: TRVX), a clinical-stage immuno-oncology company developing immune activators to target hard-to-treat solid […]
Avacta Establishes New Therapeutics Headquarters at Scale Space, Imperial College White City Campus
Avacta Group plc (AIM: AVCT), a clinical stage oncology drug company developing innovative cancer therapies […]
Largest Clinical Study Validating A Blood-based Colorectal Screening Test Completes Enrollment
Freenome, a privately held biotech company, announced the completion of enrollment for PREEMPT CRC, the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more